Stage IIB-IVA cancer of the cervix

Cancer Journal

Volumn 9, Issue 5, 2003, Pages 404-414

  Rose, Peter G ^a,b  

^a Case Western Reserve University ^*

^b METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; Chemotherapy; Locally advanced; Radiation

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

ARTICLE; BRACHYTHERAPY; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; HYPERTHERMIA; IMAGING SYSTEM; METASTASIS; MORBIDITY; PRIORITY JOURNAL; RADIATION; TREATMENT PLANNING; UTERINE CERVIX CANCER; CONTROLLED CLINICAL TRIAL; DECISION MAKING; FEMALE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; UTERINE CERVIX TUMOR;

DECISION MAKING; FEMALE; HUMANS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; UTERINE CERVICAL NEOPLASMS;

EID: 1542439965     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200309000-00011     Document Type: Article

References (89)

1. Perez CA, Grigsby PW, Nene SM et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irritation alone. Cancer 1992;69:2796.
2. Lanciano RM, Won M, Coia LR et al. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies. Int J Radiat Oncol Biol Phys 1991;20:667-676.
3. Russell AH, Shingleton HM, Jones WB et al. Diagnostic assessments in patients with invasive cancer of the cervix: a national patterns of care study of the American College of Surgeons. Gynecol Oncol 1996;63:159-165.
4. Ingram CW, Dicicco B, Pastore L et al. Hilar adenopathy and positive HIV antibody test: case report. Va Med 1989;116:122-124.
5. Heller PB, Malateno JH, Bundy BN et al. Clinical-pathologic study of stage UB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis - a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:425-430.
6. Subak LL, Hricak H, Powell B et al. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995;86:43-50.
7. Oellinger JJ, Blohmer JU, Michniewicz K et al. Pre-operative staging of cervical cancer: comparison of magnetic resonance imaging (MRI) and computed tomography (CT) with histologic results. Zentralbl Gynakol 2000;122:82-91.
8. Rose PG, Adler LP, Rodriguez M et al. Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study. J Clin Oncol 1999;17:41-45.
9. Narayan K, Hicks RJ, Jobling T et al. A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: potential impact on treatment. Int J Gynecol Cancer 2001;11:263-271.
10. Yeh LS, Hung YC, Shen YY et al. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fiuorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep 2002;9:1289-1292.
11. Lin WC, Hung YC, Yeh LS et al. Usefulness of (18) F-fluorodeoxy-glucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings: Gynecol Oncol 2003;89:73-76.
12. Park SY, Roh JW, Park YJ et al. Positron emission tomography (PET) for evaluating para-aortic and pelvic lymph node metastasis in cervical cancer before surgical staging: a surgico-pathologic study. Proc Am Soc Clin Oncol 2003;1835:456a.
13. Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 2001;19:3745-3749.
14. Weiser EB, Bundy BN, Hoskins WJ et al. Extraperitoneal versus transperitoneal selective paraaortic lymphadenectomy in the pre-treatment surgical staging of advanced cervical carcinoma (a Gynecologic Oncology Group study). Gynecol Oncol 1989;33:283-289.
15. Gallup DG, King LA, Messing MJ et al. Paraaortic lymph node sampling by means of an extraperitoneal approach with a supraumbilical transverse "sunrise" incision. Am J Obstet Gynecol 1993;169:307-311.
16. Vasilev SA, McGonigle KF. Extraperitoneal laparoscopic paraaortic lymph node dissection development of a technique. J Laparoendosc Surg 1995;5:85-90.
17. Fowler J. Controversies in cervical and endometrial cancer: a Gynecologic Oncology Group educational symposium. July 24, 2003. Reno, NV
18. Goff BA, Muntz HG, Paley PJ et al. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 1999;74:436-442.
19. Holcomb K, Abulafia O, Matthews RP et al. The impact of pretreatment staging laparotomy on survival in locally advanced cervical carcinoma. Eur J Gynaecol Oncol 1999;20:90-93.
20. Odunsi KO, Lele S, Ghamande S el al. The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer. Eur J Gynaecol Oncol 2001;22:325-330.
21. Cosin JA, Fowler JM, Chen MD et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Oncer 1998;82:2241-2248.
22. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-256.
23. Potter ME, Spencer S, Soon SJ et al. The influence of staging laparotomy for cervical cancer on patterns of recurrence and survival. Int J Gynecol Cancer 1993;3:169-174.
24. Kupets R, Thomas GM, Covens A. Is there a role for pelvic lymph node debulking in advanced cervical cancer? Gynecol Oncol 2002;87:163-170.
25. Morris M, Eifel PJ, Lu J et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: N Engl J Med 1999;340:1137-1143.
26. Stehman FB, Perez CA, Kurman RJ et al. Uterine cervix. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology, 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2000:887-903.
27. McAlpine JN, Lim P, Chen D et al. Radiation fields in gynecologic oncology: correlation of soft tissue (surgical) to radiologic landmarks. Gynecol Oncol 2003;72:191.
28. Coia L, Won M, Lanciano R et al. The Patterns of Care Outcome Study for cancer of the uterine cervix: results of the Second National Practice Survey. Cancer 1990;66:2451-2456.
29. Lanciano RM, Martz K, Coia LR et al. Tumor and treatment factors improving outcome in stage Hl-B cervix cancer. Int J Radiat Oncol Biol Phys 1991;20:95-100.
30. Lanciano RM, Martz K, Montana GS et al. Influence of age, prior abdominal surgery, fraction size, and dose on complications after radiation therapy for squamous cell cancer of the uterine cervix: a Patterns of Care study. Cancer 1992;69:2124-2130.
31. Fyles A, Keane TJ, Barton M et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-279.
32. Lanciano RM, Pajak TF, Martz K et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25:391-397.
33. Petereit DG, Sarkaria JN, Chappell R et al. The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1301-1307.
34. Eifel PJ, Moughan J, Owen J et al. Patterns of radiotherapy practice for patients with squamous cell carcinoma of the uterine cervix: patterns of care study. Int J Radiat Oncol Biol Phys 1999;43:351-358.
35. Katz A, Eifel PJ, Moughan J et al. Socioeconomic characteristics of patients with squamous cell carcinoma of the uterine cervix treated with radiotherapy in the 1992 to 1994 patterns of care study. Int J Radiat Oncol Bio Phys 2000;47:443-450.
36. Komaki R, Brickner TJ, Hanlon AL et al. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 1995;31:973-982.
37. Logsdon MD, Eifel PJ. FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999;43:763-775.
38. O'Leary AW, Rose PG, Rodriguez M et al. Ultrasound assisted intrauterine tandem placement in advanced cervical cancer. J Brachyther Int 2000;16:169-172.
39. Syed AM, Puthawala AA, Abdelaziz NN et al. Long-term results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervical. Int J Radiat Oncol Biol Phys 2002;54:67-78.
40. Nag S, Chao C, Erickson B et al. American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;52:33-48.
41. Souhami L, Seymour R, Roman T. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993;27:871-878.
42. Orton C, Seyedsadr M, Somnay A. Comparison of high and low-dose rate remote afterloading for cervix cancer and the importance of fractionation. IntJ Radiat Oncol Biol Phys 1991;21:1425-1434.
43. Akine Y, Tokita N, Ogino T et al. Dose equivalence for high-dose-rate to low-dose-rate intracavitary radiation in the treatment of cancer of the uterine cervix. Int J Radiat Oncol Biol Phys 1990;19:1511-1514.
44. Patel F, Sharma S, Negi P et al. Low-dose rate vs. high-dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial. Int J Radiat Oncol Biol Phys 1993;28:335-341.
45. Shigematsu Y, Nishiyama K, Masaki N et al. Treatment of carcinoma of the uterine cervix by remotely controlled after loading intracavitary radiotherapy with high dose-rate: a comparative study with a low dose-rate system. Int J Radiat Oncol Biol Phys 1983;9:351-356.
46. Teshima T, Inoue T, Ikeda H et al. High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Cancer 1993;72:2409-2414.
47. Hareyama M, Sakata K, Oouchi A et al. High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix: a randomized trial: Cancer 2002;94:117-124.
48. Petereit DG, Pearcey R. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? Int J Radiat Oncology Biol Phys 1999;43:359-366.
49. Lorvidhaya V, Tonusin A, Changwiwit W et al. High-dose-rate after loading brachytherapy in carcinoma of the cervix: an experience of 1992 patients. Int J Radiat Oncol Biol Phys 2000;46:1185-1191.
50. Eifel P. High-dose rate brachytherapy for carcinoma of the cervix: high tech or high risk. Int J Radiat Oncol Biol Phys 1992;24:383-386.
51. Nag S, Abitbol AA, Anderson LL et al. Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors, Clinical Research Committee, American Endocurietherapy Society. Int J Radiat Oncol Biol Phys 1993;27:1241-1244.
52. Portelance L, Chao KS, Grigsby PW et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-266.
53. Mundt AJ, Lujan AE, Rotmensch J et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;52:1330-1337.
54. Brixey CJ, Roeske JC, Lijan AE et al. Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 2002;54:1388-1396.
55. Souhami L, Gil R, Allan S et al. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. ImJ Radiat Oncol Biol Phys 1991;9:970-997.
56. Cardenas J, Olguin A, Figueroa F et al. Neoadjuvant chemotherapy (CT) + radiotherapy vs radiotherapy alone in stage IIIB cervical carcinoma: preliminary results [abstract]. Proc Am Soc Clin Oncol 1992;11:232.
57. Kumar L, Kaushal R, Nandy M et al. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 1994;54:307-315.
58. Chiara S, Bruzzone M, Merlini L et al. Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma: GONO (North-West Oncologic Cooperative Group). Am J Clin Oncol 1994;17:294-297.
59. Tattersall MHN, Larvidhaya V, Vootiprux V et al. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995;13:444-451.
60. Sundfor K, Trope CG, Hogberg T et al. Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma: a randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996;77:2371-2378.
61. Leborgne F, Leborgne JH, Doldán R et al. Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial. Int J Radiat Oncol Biol Phys 1997;37:343-350.
62. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
63. Tiemey JF, Stewart LA, Parmar MK. Can the published data tell us about the effectiveness of neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix? Eur J Cancer 1999;35:406-409.
64. National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996. Gynecol Oncol 1997;66:351-361.
65. Whitney CW, Sause W, Bundy BN et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999;17:1339-1348.
66. Rose PG, Bundy BN, Watkins EB et al. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: results of a randomized Gynecologic Oncology Group Study. N Engl J Med 1999;340:1144-1153.
67. Keys HM, Bundy BM, Siehman FB et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-1161.
68. Peters WA III, Liu PY, Barrett RJ et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 2000;18:1606-1613.
69. NCI Clinical Announcement, U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, February 1999.
70. Pearcy R, Brundage M, Drouin P et al. Phase III trial comparing radical radiation therapy with and without cisplatin chemotherapy in patients with advanced squamous cell carcinoma of the cervix. J Clin Oncol 2002;20:966-972.
71. Rose PG, Bundy BN. Chemoradiation for locally advanced cervical cancer: Does it help [editorial]? J Clin Oncol 2002;20:891-893.
72. Lanciano RM. Controversies in cervical and endometrial cancer: a Gynecologic Oncology Group educational symposium. July 24, 2003. Reno, NV
73. Lorvidhaya V, Chitapanarux I, Sangruchi S et al. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1226-1232.
74. Rakovitch E, Flyes AW, Pintilie M et al. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997;38:979-987.
75. Duenas Gonzalez A, Vazquez Govea E, Lopez Graniel CM et al. Phase II randomized study of cisplatin vs cisplatin/gemcitabine concurrent to radiation in cervical cancer stages IB2-11B. Proc Am Soc Clin Oncol 2003;22:462a.
76. Rotman M, Pajak TF, Choi K et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages UB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. J Am Med Assoc 1995;274:387-393.
77. Knocke TH, Weitmann HD, Feldmann HJ et al. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 1999;53:99-104.
78. Dehdashti F, Grigsby PW, Mintun MA et al. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. Int J Radiat Oncol Biol Phys 2003;55:1233-1238.
79. Dische S, Saunders MI, Sealy R et al. Carcinoma of the cervix and the use of hyperbaric oxygen with radiotherapy: a report of a randomised controlled trial. Radiother Oncol 1999;53:93-98.
80. Aquino-Parsons C, Lim P, Green A et al. Carbogen inhalation in cervical cancer: assessment of oxygenation change. Gynecol Oncol 1999;74:259-264.
81. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-1536.
82. Winter WE III, Maxwell LG, Cunqiao T et al. The association of hemoglobin with survival in advanced cervical carcinoma patients treated with cisplatin and radiotherapy. Gynecol Oncol 2002;84:479-536.
83. Santin AD, Bellone S, Parrish RS et al. Influence of allogeneic blood transfusion on clinical outcome during radiotherapy for cancer of the uterine cervix. Gynecol Obstet Invest 2003;56:28-34.
84. Kalra R, Singh SP, Savage SM et al. Effects of cigarette smoke on immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP-3 sensitive Ca(2 + ) stores. J Pharmacol Exp Ther 2000;293:166-171.
85. Waggoner SE, Furham B, Darcy K et al. Influence of smoking on progression-free and overall survival in women with stage II-B, III-B and IV-A cervical carcinoma: a Gynecologic Oncology Group (GOG) study. Gynecol Oncol 2003;71:190.
86. Eifel PJ, Jhingran A, Bodurka DC et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol 2002;20:3651-3657.
87. Hombeck NB, Shupe RE, Shidnia H et al. Advanced stage IIIB cancer of the cervix treatment by hyperthermia and radiation. Gynecol Oncol 1986;23:160-167.
88. van der Zee J, Gonzalez D, van Rhoon GC. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355:1119-1125.
89. Jones EL, Samulski TV, Dewhirst MW et al. A pilot phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer 2003;98:277-282.